Evidence map›Paper›PMID 30149119›Full record

ArticleClinical immunology (Orlando, Fla.)2018

IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Xin Zhang, Nazanin Kiapour, Sahil Kapoor, Joseph R Merrill, Yongjuan Xia, Woomi Ban, Stephanie M Cohen, Bentley R Midkiff, Valerie Jewells, Yen-Yu I Shih and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xin ZhangDepartment of Neurology, University of North Carolina at Chapel Hill, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, USA. Electronic address: xin.zhang193@duke.edu.
Nazanin KiapourDepartment of Neurology, University of North Carolina at Chapel Hill, USA.
Sahil KapoorDepartment of Neurology, University of North Carolina at Chapel Hill, USA.
Joseph R MerrillBiomedical Research Imaging Center, University of North Carolina, USA.
Yongjuan XiaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, USA.
Woomi BanBiomedical Research Imaging Center, University of North Carolina, USA.
Stephanie M CohenLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, USA.
Bentley R MidkiffLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, USA.
Valerie JewellsDepartment of Radiology, University of North Carolina at Chapel Hill, USA.
Yen-Yu I ShihDepartment of Neurology, University of North Carolina at Chapel Hill, USA; Biomedical Research Imaging Center, University of North Carolina, USA.
Silva Markovic-PleseDepartment of Neurology, University of North Carolina at Chapel Hill, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, USA.
University of North Carolina at Chapel Hill · USImaging Center · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
NCATS NIH HHS UL1 TR001111NCATS NIH HHS UL1 TR002489NCI NIH HHS P30 CA016086NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

IL-11 induced differentiation and expansion of Th17 cells in patients with early relapsing-remitting multiple sclerosis (RRMS). In mice with relapsing-remitting experimental autoimmune encephalomyelitis (RREAE), IL-11 exacerbated disease, induced demyelination in the central nervous system (CNS), increased the percentage of IL-17A

Indexed as

AnimalsBrainDiffusion Tensor ImagingEncephalomyelitis, Autoimmune, ExperimentalInflammationInterleukin-11Interleukin-11 Receptor alpha SubunitLeukocytes, MononuclearMiceMultiple Sclerosis, Relapsing-RemittingRecombinant Fusion ProteinsSpinal CordTh17 CellsInterleukin-11Interleukin-11 Receptor alpha SubunitRecombinant Fusion ProteinsDemyelinationDiffusion Tensor ImagingExperimental autoimmune encephalomyelitisIL-11Multiple sclerosisTh17 cells

Identifiers

PMID30149119
PMCPMC7953940
OpenAlexW2888762655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.